437 related articles for article (PubMed ID: 18355768)
21. Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.
Sassy-Prigent C; Heudes D; Jouquey S; Auberval D; Belair MF; Michel O; Hamon G; Bariety J; Bruneval P
Lab Invest; 1995 Jul; 73(1):64-71. PubMed ID: 7603042
[TBL] [Abstract][Full Text] [Related]
22. Peroxisome proliferator-activated receptor [gamma] agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity.
Baylis C; Atzpodien EA; Freshour G; Engels K
J Pharmacol Exp Ther; 2003 Dec; 307(3):854-60. PubMed ID: 14560039
[TBL] [Abstract][Full Text] [Related]
23. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T
Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458
[TBL] [Abstract][Full Text] [Related]
24. Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats.
Fan YY; Kobori H; Nakano D; Hitomi H; Mori H; Masaki T; Sun YX; Zhi N; Zhang L; Huang W; Zhu B; Li P; Nishiyama A
Horm Metab Res; 2013 May; 45(5):338-43. PubMed ID: 23322513
[TBL] [Abstract][Full Text] [Related]
25. Intrarenal oxidative stress and augmented angiotensinogen are precedent to renal injury in Zucker diabetic fatty rats.
Suzaki Y; Ozawa Y; Kobori H
Int J Biol Sci; 2006 Nov; 3(1):40-6. PubMed ID: 17200690
[TBL] [Abstract][Full Text] [Related]
26. Discrepancy between intrarenal messenger RNA and protein expression of ACE and ACE2 in human diabetic nephropathy.
Wang G; Lai FM; Lai KB; Chow KM; Kwan CH; Li KT; Szeto CC
Am J Nephrol; 2009; 29(6):524-31. PubMed ID: 19077419
[TBL] [Abstract][Full Text] [Related]
27. Enalapril improves vascular and cardiac function in streptozotocin-diabetic rats.
Crespo MJ; Dunbar DC
Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1311-8. PubMed ID: 14984003
[TBL] [Abstract][Full Text] [Related]
28. Down regulation of angiotensin II receptor AT1 expression in the pancreas of diabetic rat.
Monosíková J; Zeman M; Veselá A; Herichová I
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):438-9. PubMed ID: 19472100
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
Xu ZG; Miao LN; Cui YC; Jia Y; Yuan H; Wu M
Nephrol Dial Transplant; 2009 Jun; 24(6):1744-52. PubMed ID: 19103735
[TBL] [Abstract][Full Text] [Related]
30. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
31. Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.
Shiota A; Yamamoto K; Ohishi M; Tatara Y; Ohnishi M; Maekawa Y; Iwamoto Y; Takeda M; Rakugi H
Hypertens Res; 2010 Apr; 33(4):298-307. PubMed ID: 20186149
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes.
Fiordaliso F; Cuccovillo I; Bianchi R; Bai A; Doni M; Salio M; De Angelis N; Ghezzi P; Latini R; Masson S
Life Sci; 2006 Jun; 79(2):121-9. PubMed ID: 16445948
[TBL] [Abstract][Full Text] [Related]
33. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
[TBL] [Abstract][Full Text] [Related]
34. The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme activity.
Valentovic MA; Elliott CW; Ball JG
Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):27-39. PubMed ID: 2829328
[TBL] [Abstract][Full Text] [Related]
35. Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats.
Miyata K; Ohashi N; Suzaki Y; Katsurada A; Kobori H
Clin Exp Pharmacol Physiol; 2008 Aug; 35(8):922-7. PubMed ID: 18430060
[TBL] [Abstract][Full Text] [Related]
36. Changes in angiotensin converting enzyme activity in the renal vascular bed of streptozotocin-induced diabetic rat.
Kamata K; Mizutani K
Res Commun Mol Pathol Pharmacol; 1999; 104(2):181-92. PubMed ID: 10634311
[TBL] [Abstract][Full Text] [Related]
37. PPAR-alpha agonist fenofibrate induces renal CYP enzymes and reduces blood pressure and glomerular hypertrophy in Zucker diabetic fatty rats.
Zhao X; Li LY
Am J Nephrol; 2008; 28(4):598-606. PubMed ID: 18277067
[TBL] [Abstract][Full Text] [Related]
38. Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice.
Ebrahimian TG; Tamarat R; Clergue M; Duriez M; Levy BI; Silvestre JS
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):65-70. PubMed ID: 15528473
[TBL] [Abstract][Full Text] [Related]
39. [The expression and significance of the angiopoietin-1 in the kidney of diabetic rats].
Yang YB; Chen ZJ; Liu F; Huang SM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):93-6, 104. PubMed ID: 17294737
[TBL] [Abstract][Full Text] [Related]
40. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
Lo CS; Liu F; Shi Y; Maachi H; Chenier I; Godin N; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Am J Physiol Renal Physiol; 2012 Apr; 302(7):F840-52. PubMed ID: 22205225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
